Therapeutic management of epithelial ovarian cancer during pregnancy

ISSN： 1699-048X

Source： Clinical and Translational Oncology, Vol.15, Iss.4, 2013-04, pp. : 259-264

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future directions in the management of epithelial ovarian cancer

By Blagden Sarah Gabra Hani

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 403-411

Future Medicine

Access to resources Recommend Favorite

Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study

By Toriola Adetunji

Cancer Causes and Control, Vol. 22, Iss. 11, 2011-11 ,pp. : 1607-1611

Springer Publishing Company

Access to resources Recommend Favorite

Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 133-144

Bentham Science Publishers

Access to resources Recommend Favorite

Thoracoscopy for the Management of Advanced Epithelial Ovarian Cancer-A Preliminary Report

By Eisenkop S.M.

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 315-320

Elsevier

Access to resources Recommend Favorite

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1156-1162

Spandidos Publications

Access to resources Recommend Favorite